Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 randomized double-blind placebo-controlled multiple-dose study of AMG 853 in inadequately controlled asthma
2009-013538-26Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing AMG 853 with Placebo (2 arms). Primary endpoint: Change in ACQ symptom scores. Started Nov 2009; status: completed.
02
Drugs
Vidupiprant
03
Conditions
asthma
Beyond the preview
Go deeper on 2009-013538-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-013538-26.